Transition Therapeutics Inc. (TTHI) was a big mover last session with shares rising roughly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up over 11% in the past one month time frame.
This biopharmaceutical company has not seen any estimate revision over the last 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this stock in the near future.
Transition Therapeutics currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
However, some better-ranked stocks in the BioMed industry include Actelion Ltd. (ALIOF), Heska Corporation (HSKA) and Agenus Inc. (AGEN). While Actelion and Heska sport a Zacks Rank #1 (Strong Buy), Agenus carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment